BEVESPI AEROSPHERE INHALER

Glycopyrrolate and formoterol fumarate
$40.9856per GM

Strength

4.8; 9 ug/1; ug/1

NDC

00310460012

Classification

Brand

Dosage Form

AEROSOL, METERED

Route

RESPIRATORY (INHALATION)

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA208294

On Market Since

10/3/2016

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.7%

3Y

+9.0%

5Y

+15.5%

All

+36.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.